Eastling Thomas Wilson
Insider CIK 1958487 · GYRE Chief Financial Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GYRE GYRE THERAPEUTICS, INC. | A Award deriv | 2026-05-04 | 2026-05-06 | 33,271 | — | $0 | 33,271 | SEC↗ |
| GYRE GYRE THERAPEUTICS, INC. | A Award deriv | 2026-05-04 | 2026-05-06 | 92,683 | — | $0 | 92,683 | SEC↗ |
| GYRE GYRE THERAPEUTICS, INC. | A Award deriv | 2026-05-04 | 2026-05-06 | 95,060 | — | $0 | 95,060 | SEC↗ |
| GYRE GYRE THERAPEUTICS, INC. | A Award deriv | 2026-05-04 | 2026-05-06 | 33,271 | — | $0 | 33,271 | SEC↗ |
| GYRE GYRE THERAPEUTICS, INC. | A Award deriv | 2026-05-04 | 2026-05-06 | 11,882 | — | $0 | 11,882 | SEC↗ |
| GYRE GYRE THERAPEUTICS, INC. | A Award deriv | 2026-05-04 | 2026-05-06 | 47,530 | — | $0 | 47,530 | SEC↗ |
| GYRE GYRE THERAPEUTICS, INC. | A Award deriv | 2026-05-04 | 2026-05-06 | 95,060 | — | $0 | 95,060 | SEC↗ |
| GYRE GYRE THERAPEUTICS, INC. | A Award deriv | 2025-06-04 | 2025-06-06 | 26,000 | — | $0 | 26,000 | SEC↗ |
| GYRE GYRE THERAPEUTICS, INC. | M Exercise deriv | 2025-04-16 | 2025-04-18 | 15,000 | — | $0 | 299,652 | SEC↗ |
| GYRE GYRE THERAPEUTICS, INC. | M Exercise | 2025-04-16 | 2025-04-18 | 15,000 | $6.93 | $104.0K | 15,000 | SEC↗ |
| GYRE GYRE THERAPEUTICS, INC. | A Award deriv | 2024-08-14 | 2024-08-16 | 26,000 | — | $0 | 26,000 | SEC↗ |
| GYRE GYRE THERAPEUTICS, INC. | A Award deriv | 2023-10-31 | 2023-11-01 | 1,866 | — | $0 | 1,866 | SEC↗ |
| GYRE GYRE THERAPEUTICS, INC. | A Award deriv | 2023-10-31 | 2023-11-01 | 314,652 | — | $0 | 314,652 | SEC↗ |